Impact of routine vaccination with a conjugate Haemophilus influenzae type b vaccine

Vaccine

Volumn 22, Issue 3-4, 2004, Pages 378-382

  Hviid, Anders ^a   Melbye, Mads ^a  

^a DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

Author keywords

Epidemiology; Haemophilus influenzae type b; Vaccination

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; BACTERIAL MENINGITIS; CHILD; DRUG CONJUGATION; DRUG EFFICACY; HERD IMMUNITY; HUMAN; INFLUENZA VACCINATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0345096577     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.08.001     Document Type: Article

References (22)

1. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev. 13(2):2000;302-317.
2. Booy R., Heath P.T., Slack M.P., Begg N., Moxon E.R. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet. 349(9060):1997;1197-1202.
3. Dagan R., Fraser D., Roitman M., Slater P., Anis E., Ashkenazi S.et al. Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. The Israeli Pediatric Bacteremia and Meningitis Group. Vaccine. 17(2):1999;134-141.
4. Garpenholt O., Hugosson S., Fredlund H., Giesecke J., Olcen P. Invasive disease due to Haemophilus influenzae type b during the first six years of general vaccination of Swedish children. Acta Paediatr. 89(4):2000;471-474.
5. Peltola H., Kilpi T., Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet. 340(8819):1992;592-594.
6. Peltola H., Aavitsland P., Hansen K.G., Jonsdottir K.E., Nokleby H., Romanus V. Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia. J. Infect. Dis. 179(1):1999;223-229.
7. van Alphen L., Spanjaard L., van der E.A., Schuurman I., Dankert J. Effect of nationwide vaccination of 3-month-old infants in The Netherlands with conjugate Haemophilus influenzae type b vaccine: high efficacy and lack of herd immunity. J. Pediatr. 131(6):1997;869-873.
8. Wenger J.D. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. Pediatr. Infect. Dis. J. 17(9 suppl):1998;S132-S136.
9. Gade K., Rønne T. Vaccination mod Haemophilus influenzae B (Hib). EPI NYT. 20b:1993;1.
10. Kristensen MB, Friis H, Rassing MR. Lægemiddel kataloget. Copenhagen: Dansk Lægemiddel Information A/S; 2000.
11. Booy R., Taylor S.A., Dobson S.R., Isaacs D., Sleigh G., Aitken S.et al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch. Dis. Child. 67(4):1992;475-478.
12. Booy R., Hodgson S., Carpenter L., Mayon-White R.T., Slack M.P., Macfarlane J.A.et al. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet. 344(8919):1994;362-366.
13. Gade K. Vaccination against Haemophilus influenzae type b (Hib) in the Danish Childhood Vaccination Programme: programme evaluation concerning impact, adverse events and parental support. Denmark: University of Copenhagen; 1997.
14. Plesner A.M., Gade K., Rønne T. Nyt børnevaccinations program. EPI NYT. 50:1996;1.
15. Westergaard T., Andersen P.K., Pedersen J.B., Olsen J.H., Frisch M., Sorensen H.T.et al. Birth characteristics, sibling patterns, and acute leukemia risk in childhood: a population-based cohort study. J. Natl. Cancer Inst. 89(13):1997;939-947.
16. Clayton D, Hills M. Poisson and logistic regression. In: Statistical models in epidemiology, chapter 23, first ed. Oxford: Oxford University Press; 1993. p. 227-36.
17. Giesecke J. The epidemiology of vaccination. In: Modern infectious disease epidemiology, chapter 19, second ed. Pans: Arnold; 2002. p. 226-40.
18. Mohle-Boetani J.C., Ajello G., Breneman E., Deaver K.A., Harvey C., Plikaytis B.D.et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr. Infect. Dis. J. 12(7):1993;589-593.
19. Murphy T.V., Pastor P., Medley F., Osterholm M.T., Granoff D.M. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J. Pediatr. 122(4):1993;517-523.
20. Barbour M.L., Mayon-White R.T., Coles C., Crook D.W., Moxon E.R. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J. Infect. Dis. 171(1):1995;93-98.
21. Muhlemann K., Alexander E.R., Pepe M., Weiss N.S., Schopfer K. Invasive Haemophilus influenzae disease and epiglottitis among Swiss children from 1980 to 1993: evidence for herd immunity among older age groups. The Swiss Haemophilus influenzae Study Group. Scand. J. Infect. Dis. 28(3):1996;265-268.
22. Takala A.K., Eskola J., Leinonen M., Kayhty H., Nissinen A., Pekkanen E.et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J. Infect. Dis. 164(5):1991;982-986.